Update date
31 Mar 2025
Shareable Research Card
Elevation Oncology, Inc. Share-based Payment Arrangement, Noncash Expense
This metric view shows Elevation Oncology, Inc. share-based payment arrangement, noncash expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2025
- Latest reported value
- $987,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2025
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2025.
- Latest reported value on this page: $987,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Share-based Payment Arrangement, Noncash Expense
Latest reported share-based payment arrangement, noncash expense: $987,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2025
SEC-backed company facts were refreshed from filings filed on 15 May 2025.
Benchmark Context
How Share-based Payment Arrangement, Noncash Expense compares with peers
Elevation Oncology, Inc. is outside the visible top 120 companies for share-based payment arrangement, noncash expense in the current sample.
Compared with
Compared with 120 companies reporting share-based payment arrangement, noncash expense in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Share-based Payment Arrangement, Noncash Expense is up about 9.4% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2013 to 28 Feb 2026.
- Nearby companies in this sample: Alphabet Inc. and Meta Platforms, Inc..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Elevation Oncology, Inc.: Share-based Payment Arrangement, Noncash Expense
Latest period: Q1 2025. Period end: 31 Mar 2025. Units: USD. Frequency: quarterly and annual.
Amount of noncash expense for share-based payment arrangement.
Metric Snapshot
- Latest value
- $987,000
- Coverage range
- 31 Dec 2020 - 31 Mar 2025
- Fact rows
- 10
What This Metric Tells You
- Shows the reported level of share-based payment arrangement, noncash expense over 31 Dec 2020 - 31 Mar 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 10 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Share-based Payment Arrangement, Noncash Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Alphabet Inc. (googl) | $24,953,000,000 | Year - 31 Dec 2025 | Open Alphabet Inc. Share-based Payment Arrangement, Noncash Expense |
| 2 | Meta Platforms, Inc. (meta) | $20,427,000,000 | Year - 31 Dec 2025 | Open Meta Platforms, Inc. Share-based Payment Arrangement, Noncash Expense |
| 3 | AMAZON COM INC (amzn) | $19,467,000,000 | Year - 31 Dec 2025 | Open AMAZON COM INC Share-based Payment Arrangement, Noncash Expense |
| 4 | Alibaba Group Holding Ltd (baba) | $7,650,000,000 | Year - 31 Mar 2021 | Open Alibaba Group Holding Ltd Share-based Payment Arrangement, Noncash Expense |
| 5 | NVIDIA CORP (nvda) | $6,386,000,000 | Year - 25 Jan 2026 | Open NVIDIA CORP Share-based Payment Arrangement, Noncash Expense |
| 6 | Next Meats Holdings, Inc. (nxmh) | $5,880,579,874 | Year - 30 Apr 2021 | Open Next Meats Holdings, Inc. Share-based Payment Arrangement, Noncash Expense |
Metric Details
- Metric
- Share-based Payment Arrangement, Noncash Expense (ShareBasedCompensation)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2020 - 31 Mar 2025
- Facts on this page
- 10
- Description
- Amount of noncash expense for share-based payment arrangement.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
Elevation Oncology, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2025 | $987,000 | +$85,000 | +9.4% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 15 May 2025 | 2025 | Q1 | |
| Q1 2024 | $902,000 | -$562,000 | -38% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 15 May 2025 | 2025 | Q1 | |
| Q1 2023 | $1,464,000 | +$837,000 | +133% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 02 May 2024 | 2024 | Q1 | |
| Q1 2022 | $627,000 | +$562,000 | +865% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 15 May 2023 | 2023 | Q1 | |
| Q1 2021 | $65,000 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 05 May 2022 | 2022 | Q1 |
Elevation Oncology, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | $4,280,000 | +$945,000 | +28% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 06 Mar 2025 | 2024 | FY |
| 2023 | $3,335,000 | +$129,000 | +4% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 06 Mar 2025 | 2024 | FY |
| 2022 | $3,206,000 | +$1,635,000 | +104% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 06 Mar 2024 | 2023 | FY |
| 2021 | $1,571,000 | +$1,519,000 | +2921% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 09 Mar 2023 | 2022 | FY |
| 2020 | $52,000 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 03 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.